Outlook Therapeutics
OTLK
$8.50
Share price
-4.71%
Change (1 day)
626.50%
Change (1 year)
Categories
EPS for Outlook Therapeutics (OTLK)
EPS in 2023 (TTM): -$0.25
According to Outlook Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.25. In 2022 the company made an earnings per share (EPS) of -$0.31 an increase over its 2021 EPS that were of -$0.32.
EPS history for Outlook Therapeutics from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.25 | -19.35% |
| 2022 | -$0.31 | -3.13% |
| 2021 | -$0.32 | -45.58% |
| 2020 | -$0.59 | -72.76% |
| 2019 | -$2.16 | -69.86% |
| 2018 | -$7.16 | -42.98% |
| 2017 | -$12.56 | -45.12% |
| 2016 | -$22.88 | -32.39% |
| 2015 | -$33.85 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -$2.06 | 724.00% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -$6.20 | 2,380.00% | 🇬🇧 UK |
 Novavax NVAX | -$7.19 | 2,776.00% | 🇺🇸 USA |
 Novocure
NVCR | -$1.86 | 644.00% | Jersey |